COVID-19 vaccines and the pandemic’s third year

The U.S. and Europe have shifted their focus toward booster doses, which have been proven critical in protection against omicron. As omicron lays the enduring threat from a mutating coronavirus and new variants, learn the latest developments in the COVID-19 vaccine.


  • Moderna to seek clearance for COVID-19 vaccine in young children
  • Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill
  • Pfizer, Moderna sued over technology used in COVID vaccines
Share the Post:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to our use of all cookies, however, you may visit “Cookies Setting” to provide a controlled consent.

Privacy Policy